Global Critical Care diagnostics Market

Critical Care diagnostics Comprehensive Study by Test (Flow Cytometry, Hematology Test, Microbiology and Infectious Test, Coagulation Test, Immunoprotein, Routine and Special Chemistry, Others), End User (Operating Room, Emergency Room, Intensive Care Unit, Others) Players and Region - Global Market Outlook to 2026

Critical Care diagnostics Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Critical Care diagnostics Market Overview:
The growing global prevalence of chronic and lifestyle-related illnesses, as well as developments in diagnostic technologies, are driving the critical care diagnostics market. Furthermore, rising public awareness of the importance of early diagnosis and treatment, increased use of data management and connectivity through interoperability with electronic health records (EHR), and increased adoption of telehealth services and remote communications are all driving the Critical Care Diagnostics Market forward.

Growth Drivers
  • Rise in the Prevalence of Chronic Diseases and Lifestyle-related Disorders
  • Increase in Data Management and Connectivity through Interoperability to Electronic Health Record (EHR)

Roadblocks
  • High Cost of Molecular Diagnostics Tools

Opportunities
  • Massive Investments in R&D by Key Players
  • Government Initiatives in Implementing Critical Care Diagnostics and Improving Reimbursement Scenario

Challenges
  • Lack of Skilled Professionals


Competitive Landscape:
The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to avail of competitive advantage through combined collaborations.
Some of the key players profiled in the report are Abbott Laboratories (United States), Bayer AG (Germany), Becton, Dickinson and Company (United States), bioMerieux SA (France), Bio-Rad Laboratories, Inc. (United States), Chembio Diagnostic Systems, Inc. (United States), Danaher Corporation (United States), F. Hoffmann-La Roche (Switzerland), Siemens Healthineers (Germany) and Sysmex Corporation (Japan). Analyst at AMA Research see Global Players to retain maximum share of Global Critical Care diagnostics market by 2026. Considering Market by Test, the sub-segment i.e. Flow Cytometry will boost the Critical Care diagnostics market. Considering Market by End User, the sub-segment i.e. Operating Room will boost the Critical Care diagnostics market.

Latest Market Insights:
On June 28, 2019, C2Dx Acquires STIC Intra-Compartmental Pressure Monitoring System from Stryker Corporation.

On July 22, 2021, Ortho Clinical Diagnostics announced its VITROS® Immunodiagnostic Products IL-6 Reagent Pack, the latest addition to Ortho's VITROS® Critical Care menu, is now available in EU Countries, the U.K. and several ASPAC and LATAM countries.

What Can be Explored with the Critical Care diagnostics Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Critical Care diagnostics Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Critical Care diagnostics
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Critical Care diagnostics market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Critical Care diagnostics market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Critical Care Diagnostics Devices Manufactures, Critical Care Diagnostics Devices Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Test
  • Flow Cytometry
  • Hematology Test
  • Microbiology and Infectious Test
  • Coagulation Test
  • Immunoprotein
  • Routine and Special Chemistry
  • Others

By End User
  • Operating Room
  • Emergency Room
  • Intensive Care Unit
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise in the Prevalence of Chronic Diseases and Lifestyle-related Disorders
      • 3.2.2. Increase in Data Management and Connectivity through Interoperability to Electronic Health Record (EHR)
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. Advancements in Diagnostic Technologies.
      • 3.4.2. Rising Demand for Early Diagnosis and Treatment
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Critical Care diagnostics, by Test, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Critical Care diagnostics (Value)
      • 5.2.1. Global Critical Care diagnostics by: Test (Value)
        • 5.2.1.1. Flow Cytometry
        • 5.2.1.2. Hematology Test
        • 5.2.1.3. Microbiology and Infectious Test
        • 5.2.1.4. Coagulation Test
        • 5.2.1.5. Immunoprotein
        • 5.2.1.6. Routine and Special Chemistry
        • 5.2.1.7. Others
      • 5.2.2. Global Critical Care diagnostics by: End User (Value)
        • 5.2.2.1. Operating Room
        • 5.2.2.2. Emergency Room
        • 5.2.2.3. Intensive Care Unit
        • 5.2.2.4. Others
      • 5.2.3. Global Critical Care diagnostics Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Critical Care diagnostics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bayer AG (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Becton, Dickinson and Company (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. BioMerieux SA (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Chembio Diagnostic Systems, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Danaher Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. F. Hoffmann-La Roche (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Siemens Healthineers (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Sysmex Corporation (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Critical Care diagnostics Sale, by Test, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Critical Care diagnostics (Value)
      • 7.2.1. Global Critical Care diagnostics by: Test (Value)
        • 7.2.1.1. Flow Cytometry
        • 7.2.1.2. Hematology Test
        • 7.2.1.3. Microbiology and Infectious Test
        • 7.2.1.4. Coagulation Test
        • 7.2.1.5. Immunoprotein
        • 7.2.1.6. Routine and Special Chemistry
        • 7.2.1.7. Others
      • 7.2.2. Global Critical Care diagnostics by: End User (Value)
        • 7.2.2.1. Operating Room
        • 7.2.2.2. Emergency Room
        • 7.2.2.3. Intensive Care Unit
        • 7.2.2.4. Others
      • 7.2.3. Global Critical Care diagnostics Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Critical Care diagnostics: by Test(USD Million)
  • Table 2. Critical Care diagnostics Flow Cytometry , by Region USD Million (2015-2020)
  • Table 3. Critical Care diagnostics Hematology Test , by Region USD Million (2015-2020)
  • Table 4. Critical Care diagnostics Microbiology and Infectious Test , by Region USD Million (2015-2020)
  • Table 5. Critical Care diagnostics Coagulation Test , by Region USD Million (2015-2020)
  • Table 6. Critical Care diagnostics Immunoprotein , by Region USD Million (2015-2020)
  • Table 7. Critical Care diagnostics Routine and Special Chemistry , by Region USD Million (2015-2020)
  • Table 8. Critical Care diagnostics Others , by Region USD Million (2015-2020)
  • Table 9. Critical Care diagnostics: by End User(USD Million)
  • Table 10. Critical Care diagnostics Operating Room , by Region USD Million (2015-2020)
  • Table 11. Critical Care diagnostics Emergency Room , by Region USD Million (2015-2020)
  • Table 12. Critical Care diagnostics Intensive Care Unit , by Region USD Million (2015-2020)
  • Table 13. Critical Care diagnostics Others , by Region USD Million (2015-2020)
  • Table 14. South America Critical Care diagnostics, by Country USD Million (2015-2020)
  • Table 15. South America Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 16. South America Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 17. Brazil Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 18. Brazil Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 19. Argentina Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 20. Argentina Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 21. Rest of South America Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 22. Rest of South America Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 23. Asia Pacific Critical Care diagnostics, by Country USD Million (2015-2020)
  • Table 24. Asia Pacific Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 25. Asia Pacific Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 26. China Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 27. China Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 28. Japan Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 29. Japan Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 30. India Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 31. India Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 32. South Korea Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 33. South Korea Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 34. Taiwan Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 35. Taiwan Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 36. Australia Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 37. Australia Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 38. Rest of Asia-Pacific Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 39. Rest of Asia-Pacific Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 40. Europe Critical Care diagnostics, by Country USD Million (2015-2020)
  • Table 41. Europe Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 42. Europe Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 43. Germany Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 44. Germany Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 45. France Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 46. France Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 47. Italy Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 48. Italy Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 49. United Kingdom Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 50. United Kingdom Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 51. Netherlands Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 52. Netherlands Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 53. Rest of Europe Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 54. Rest of Europe Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 55. MEA Critical Care diagnostics, by Country USD Million (2015-2020)
  • Table 56. MEA Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 57. MEA Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 58. Middle East Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 59. Middle East Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 60. Africa Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 61. Africa Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 62. North America Critical Care diagnostics, by Country USD Million (2015-2020)
  • Table 63. North America Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 64. North America Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 65. United States Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 66. United States Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 67. Canada Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 68. Canada Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 69. Mexico Critical Care diagnostics, by Test USD Million (2015-2020)
  • Table 70. Mexico Critical Care diagnostics, by End User USD Million (2015-2020)
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Critical Care diagnostics: by Test(USD Million)
  • Table 82. Critical Care diagnostics Flow Cytometry , by Region USD Million (2021-2026)
  • Table 83. Critical Care diagnostics Hematology Test , by Region USD Million (2021-2026)
  • Table 84. Critical Care diagnostics Microbiology and Infectious Test , by Region USD Million (2021-2026)
  • Table 85. Critical Care diagnostics Coagulation Test , by Region USD Million (2021-2026)
  • Table 86. Critical Care diagnostics Immunoprotein , by Region USD Million (2021-2026)
  • Table 87. Critical Care diagnostics Routine and Special Chemistry , by Region USD Million (2021-2026)
  • Table 88. Critical Care diagnostics Others , by Region USD Million (2021-2026)
  • Table 89. Critical Care diagnostics: by End User(USD Million)
  • Table 90. Critical Care diagnostics Operating Room , by Region USD Million (2021-2026)
  • Table 91. Critical Care diagnostics Emergency Room , by Region USD Million (2021-2026)
  • Table 92. Critical Care diagnostics Intensive Care Unit , by Region USD Million (2021-2026)
  • Table 93. Critical Care diagnostics Others , by Region USD Million (2021-2026)
  • Table 94. South America Critical Care diagnostics, by Country USD Million (2021-2026)
  • Table 95. South America Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 96. South America Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 97. Brazil Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 98. Brazil Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 99. Argentina Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 100. Argentina Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 101. Rest of South America Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 102. Rest of South America Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 103. Asia Pacific Critical Care diagnostics, by Country USD Million (2021-2026)
  • Table 104. Asia Pacific Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 105. Asia Pacific Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 106. China Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 107. China Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 108. Japan Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 109. Japan Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 110. India Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 111. India Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 112. South Korea Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 113. South Korea Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 114. Taiwan Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 115. Taiwan Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 116. Australia Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 117. Australia Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 118. Rest of Asia-Pacific Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 119. Rest of Asia-Pacific Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 120. Europe Critical Care diagnostics, by Country USD Million (2021-2026)
  • Table 121. Europe Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 122. Europe Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 123. Germany Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 124. Germany Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 125. France Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 126. France Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 127. Italy Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 128. Italy Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 129. United Kingdom Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 130. United Kingdom Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 131. Netherlands Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 132. Netherlands Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 133. Rest of Europe Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 134. Rest of Europe Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 135. MEA Critical Care diagnostics, by Country USD Million (2021-2026)
  • Table 136. MEA Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 137. MEA Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 138. Middle East Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 139. Middle East Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 140. Africa Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 141. Africa Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 142. North America Critical Care diagnostics, by Country USD Million (2021-2026)
  • Table 143. North America Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 144. North America Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 145. United States Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 146. United States Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 147. Canada Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 148. Canada Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 149. Mexico Critical Care diagnostics, by Test USD Million (2021-2026)
  • Table 150. Mexico Critical Care diagnostics, by End User USD Million (2021-2026)
  • Table 151. Research Programs/Design for This Report
  • Table 152. Key Data Information from Secondary Sources
  • Table 153. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Critical Care diagnostics: by Test USD Million (2015-2020)
  • Figure 5. Global Critical Care diagnostics: by End User USD Million (2015-2020)
  • Figure 6. South America Critical Care diagnostics Share (%), by Country
  • Figure 7. Asia Pacific Critical Care diagnostics Share (%), by Country
  • Figure 8. Europe Critical Care diagnostics Share (%), by Country
  • Figure 9. MEA Critical Care diagnostics Share (%), by Country
  • Figure 10. North America Critical Care diagnostics Share (%), by Country
  • Figure 11. Global Critical Care diagnostics share by Players 2020 (%)
  • Figure 12. Global Critical Care diagnostics share by Players (Top 3) 2020(%)
  • Figure 13. Global Critical Care diagnostics share by Players (Top 5) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 16. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 17. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 18. Bayer AG (Germany) Revenue: by Geography 2020
  • Figure 19. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 20. Becton, Dickinson and Company (United States) Revenue: by Geography 2020
  • Figure 21. BioMerieux SA (France) Revenue, Net Income and Gross profit
  • Figure 22. BioMerieux SA (France) Revenue: by Geography 2020
  • Figure 23. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2020
  • Figure 25. Chembio Diagnostic Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Chembio Diagnostic Systems, Inc. (United States) Revenue: by Geography 2020
  • Figure 27. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 28. Danaher Corporation (United States) Revenue: by Geography 2020
  • Figure 29. F. Hoffmann-La Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. F. Hoffmann-La Roche (Switzerland) Revenue: by Geography 2020
  • Figure 31. Siemens Healthineers (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Siemens Healthineers (Germany) Revenue: by Geography 2020
  • Figure 33. Sysmex Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 34. Sysmex Corporation (Japan) Revenue: by Geography 2020
  • Figure 35. Global Critical Care diagnostics: by Test USD Million (2021-2026)
  • Figure 36. Global Critical Care diagnostics: by End User USD Million (2021-2026)
  • Figure 37. South America Critical Care diagnostics Share (%), by Country
  • Figure 38. Asia Pacific Critical Care diagnostics Share (%), by Country
  • Figure 39. Europe Critical Care diagnostics Share (%), by Country
  • Figure 40. MEA Critical Care diagnostics Share (%), by Country
  • Figure 41. North America Critical Care diagnostics Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Bayer AG (Germany)
  • Becton, Dickinson and Company (United States)
  • bioMerieux SA (France)
  • Bio-Rad Laboratories, Inc. (United States)
  • Chembio Diagnostic Systems, Inc. (United States)
  • Danaher Corporation (United States)
  • F. Hoffmann-La Roche (Switzerland)
  • Siemens Healthineers (Germany)
  • Sysmex Corporation (Japan)
Select User Access Type

Key Highlights of Report


Sep 2021 221 Pages 51 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Critical Care diagnostics Market Quantitative research analysis
Global Critical Care diagnostics Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Critical Care diagnostics market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Critical Care diagnostics market are Abbott Laboratories (United States), Bayer AG (Germany), Becton, Dickinson and Company (United States), bioMerieux SA (France), Bio-Rad Laboratories, Inc. (United States), Chembio Diagnostic Systems, Inc. (United States), Danaher Corporation (United States), F. Hoffmann-La Roche (Switzerland), Siemens Healthineers (Germany) and Sysmex Corporation (Japan), to name a few.
"Advancements in Diagnostic Technologies. " is seen as one of major influencing trends for Critical Care diagnostics Market during projected period 2020-2026.

Know More About Global Critical Care diagnostics Market Report?

Have a Query? Click Here

Other Related Reports

Familial Adenomatous Polyposis Treatment Comprehensive Study by Type (Icosapent, Eflornithine Hydrochloride, Aspirin, CEQ-508, Others), Application (Clinic, Hospital, Others), Familial Adenomatous Po...
$ 3750
Aromatherapy Essential Oil Comprehensive Study by Type (Lavender, Peppermint, Lemon, Tea Tree, Bergamot, Rosemary, Eucalyptus, Ginger, Geranium, Mandarin), Application (Cosmetic, Massage, Medical, Ol...
$ 3450
Asthma Therapeutics Comprehensive Study by Type (Dry Powder Inhalers, Metered Dose Inhalers, Mist Inhalers, Nebulizer), Route Of Administration (Inhalation, Oral, Parenteral), Drug Class (Anti-Inflam...
$ 3650
Bacterial Vaginosis Drugs Comprehensive Study by Type (Oral, Topical), Application (Pelvic Inflammatory Disease, Preterm Delivery of Infants, Urinary Tract Infection, Sexually Transmitted Diseases (S...
$ 3750
Sickle Cell Disease Treatment Comprehensive Study by Type (Sickle Cell Anemia, Sickle Beta Thalassemia, Sickle Hemoglobin C Disease), Application (Hospitals, Clinics, Others), Medication (Antimetabol...
$ 3650
Exosome Diagnostics and Therapeutics Comprehensive Study by Type (Diagnostic, Therapeutic), Application (Cancer Institute, Hospital, Diagnostic Center, Others), Components (Instrument, Reagent, Softw...
$ 3750